DQY: Catheter, Percutaneous
What it covers
A percutaneous catheter is a device that is introduced into a vein or artery through the skin using a dilator and a sheath (introducer) or guide wire.
The identification in 21 CFR 870.1250, percutaneous catheter. FDA gives DQY no definition of its own, so the regulation’s describes it.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K262817 | CrossFAST Integrated Microcatheter Advanced Delivery System | Vantis Vascular, Inc. | Sep 18, 2026 | Special |
| K260559 | NHanceIT | IMDS Operation B.V. | Aug 14, 2026 | Traditional |
| K262392 | APRO 35 Swift Catheter | Alembic, LLC | Aug 12, 2026 | Special |
| K262240 | SSPC NXT Delivery Catheter | CenterPoint Systems, LLC | Jul 29, 2026 | Special |
| K261766 | CPS Locator 3D Plus Delivery Catheter | CenterPoint Systems, LLC | Jul 29, 2026 | Special |
| K261825 | Amplatzer TorqVue LP Delivery System; Amplatzer TorqVue LP Catheter | Abbott | Jul 2, 2026 | Special |
| K261631 | Amplatzer TorqVue Exchange System | Abbott Medical | Jun 17, 2026 | Special |
| K260289 | Perfect-O Ostial Positioning Catheter | Balosmark, Inc. | Jun 5, 2026 | Traditional |
| K260993 | Amplatzer TorqVue Delivery System | Abbott | Apr 24, 2026 | Special |
| K253361 | Teleport Glide Microcatheter | OrbusNeich Medical (Shenzhen) Co., Ltd. | Apr 10, 2026 | Traditional |
Clearances by year
369 DQY 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 11 | 30 |
| 2025 | 21 | 115 |
| 2024 | 16 | 87 |
| 2023 | 18 | 114 |
| 2022 | 18 | 74 |
| 2021 | 18 | 81 |
| 2020 | 20 | 120 |
| 2019 | 30 | 111 |
| 2018 | 25 | 106 |
| 2017 | 26 | 113 |
| 2016 | 22 | 117 |
| 2015 | 27 | 118 |
| 2014 | 19 | 127 |
| 2013 | 32 | 92 |
| 2012 | 30 | 87 |
| 2011 | 36 | 71 |
Who submits
143 applicants cleared a DQY device since 2011. 88% of the clearances went to applicants in United States, then Japan (4%), Netherlands (3%) and Ireland (2%). By type: Traditional 64%, Special 35% and Abbreviated 0%. 25 went through a third-party review organization.
| Applicant | Clearances since 2011 |
|---|---|
| ABBOTT MEDICAL | 12 |
| Asahi Intecc Co., Ltd. | 12 |
| Biotronik, Inc. | 12 |
| MicroVention, Inc. | 12 |
| Vascular Solutions, Inc. | 11 |
| Boston Scientific Corporation | 9 |
| Medtronic, Inc. | 9 |
| Reflow Medical | 9 |
How FDA classifies it
Class II (performance standards).
From 21 CFR 870.1250.
Standards
21 CFR 870.1250 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent DQY clearances declared.
Ask about DQY
Questions about DQY
What is FDA product code DQY?
Product code DQY, “Catheter, Percutaneous” in FDA's classification database, is a Class II device type under 21 CFR 870.1250 (percutaneous catheter), reviewed by FDA's Cardiovascular panel. FDA's 510(k) database lists 896 clearances under DQY, 369 of them since 2011.
How many 510(k) clearances are there under DQY?
FDA’s 510(k) database listed 896 clearances under DQY as of Oct 29, 2026, 369 of them decided since 2011; the most recent decision was Sep 18, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a DQY 510(k)?
For the 36 DQY clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 104 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most DQY clearances?
Since 2011: ABBOTT MEDICAL (12), Asahi Intecc Co., Ltd. (12), Biotronik, Inc. (12), MicroVention, Inc. (12) and Vascular Solutions, Inc. (11). 143 applicants have cleared a DQY device in that time.